Colorado psychedelic therapy program considers expanding options

Colorado will review regulations for its state-licensed psychedelic therapy and natural medicine program, potentially expanding which substances patients can receive. The Natural Medicine Advisory Board’s prior recommendation could lead Colorado to add ibogaine, which Axios notes would make Colorado the first U.S. state to use ibogaine for regulated medical treatment. The state would need approval from two agencies before changes take effect. Currently, psilocybin is the only natural medicine available in licensed healing centers. Colorado is also evaluating how to integrate ibogaine into the existing framework, with additional consideration for DMT and mescaline (not sourced from peyote) for a possible recommendation beginning July 1. The program’s regulatory review is expected to start in spring.